Ansell impresses investors despite difficult trading environment

After a disappointing first half the company announced a full-year cash profit of US$139 million, sending the shares up over 5% in early trade today.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Ansell (ASX: ANN) reported total sales of $US 1.37 billion, up 9% on the prior year with earnings before income tax (EBIT) up 11%. The company said it expects EBIT growth in the high single digits to low teens for FY 2014.

The health device manufacturer and condom maker identified several external environment headwinds on its full-year results. Manufacturing costs, foreign exchange impacts, competitive pressures and lower government healthcare spends are creating tough operating conditions.

Ansell is a truly global business with less than 6% of sales coming from Australia and fast growing emerging markets now representing 27% of sales. More than 60% of institutional ownership is held outside Australia and the company will report and operate in US dollars from the current financial year onwards.

The business launched 48 new products in the year at a rate nearly seven times higher than 2010. It also completed four new acquisitions, including the largest deal since 1995. Leveraged to the global macro environment a return to growth in Europe would benefit it.

A final dividend of 22 cents was announced, taking the full year payout to 38 cents, up 7% on the prior year. Earnings per share and cash profit were both up 5% for the year.

Foolish takeaway

The group's balance sheet remains strong and given the necessity of its products and growth profile fundamentals the company's continued success comes as no surprise. The stock is heading towards all-time highs but this should not put off investors in for the long-term.

Interested in our #1 dividend-paying stock? Discover The Motley Fool's favourite income idea for 2013-2014 in our brand-new, FREE research report, including a full investment analysis! Simply click here for your FREE copy of "The Motley Fool's Top Dividend Stock for 2013-2014."

More reading


Motley Fool contributor Tom Richardson does not own shares in any of the companies mentioned in this article.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »